Last reviewed · How we verify
IV Caldolor
At a glance
| Generic name | IV Caldolor |
|---|---|
| Also known as | IV ibuprofen, Opioid Sparing group |
| Sponsor | St. Joseph's Hospital and Medical Center, Phoenix |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Preemptive IV Ibuprofen for Neurocognitive Recovery and Analgesic Needs After Inguinal Hernia Surgery (PHASE4)
- Phase 2 Herniorrhaphy Study for Opioid Elimination (PHASE2)
- Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstructive Sleep Apnea (NA)
- Postoperative Analgesic Efficacy of SPSIPB in Anterior Cervical Discectomy (NA)
- HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers (PHASE1, PHASE2)
- Effect of Perioperative IV Ibuprofen on Cerebral Oxygenation and Postoperative Cognition During One-Lung Ventilation (NA)
- Opioid-Free Pain Protocol After Shoulder Arthroplasty (PHASE4)
- Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IV Caldolor CI brief — competitive landscape report
- IV Caldolor updates RSS · CI watch RSS
- St. Joseph's Hospital and Medical Center, Phoenix portfolio CI